Bluejay Diagnostics, Inc. Interest Income (Expense), Net
Bluejay Diagnostics, Inc. (BJDX) reported Interest Income (Expense), Net of -$367.46 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-20.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2023-03-20
- Bluejay Diagnostics, Inc. interest income (expense), net for the quarter ending 2021-12-31 was -$97.91K.
- Bluejay Diagnostics, Inc. interest income (expense), net for the quarter ending 2021-09-30 was -$237.43K, a 1599.58% decline year-over-year.
- Bluejay Diagnostics, Inc. interest income (expense), net for the quarter ending 2021-06-30 was -$59.17K.
- Bluejay Diagnostics, Inc. interest income (expense), net for the quarter ending 2021-03-31 was $27.05K.
- Bluejay Diagnostics, Inc. interest income (expense), net for fiscal 2021 was -$367.46K.
- Bluejay Diagnostics, Inc. interest income (expense), net for fiscal 2020 was -$27.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$97.91K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$335.34K derived: sum of 2 quarters · filed 2023-03-20 | -$394.51K derived: sum of 3 quarters · filed 2023-03-20 | -$367.46K 10-K · filed 2023-03-20 |
| 2021-09-30 | -$237.43K 10-Q · filed 2022-11-09 | -$296.60K derived: sum of 2 quarters · filed 2022-11-09 | -$269.55K 10-Q · filed 2022-11-09 | -$336.99K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$59.17K 10-Q · filed 2022-08-10 | -$32.12K 10-Q · filed 2022-08-10 | -$99.56K derived: sum of 3 quarters · filed 2022-08-10 | -$83.72K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $27.05K 10-Q · filed 2022-05-09 | -$40.39K derived: sum of 2 quarters · filed 2022-05-09 | -$24.56K derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$67.44K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$51.61K derived: sum of 2 quarters · filed 2022-03-10 | -$27.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $15.83K 10-Q · filed 2021-12-16 | $40.44K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |